Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis
Authors
Keywords
-
Journal
JOURNAL OF INVESTIGATIVE MEDICINE
Volume -, Issue -, Pages svn-2020-000388
Publisher
BMJ
Online
2020-07-02
DOI
10.1136/svn-2020-000388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
- (2020) Pengfei Yang et al. NEW ENGLAND JOURNAL OF MEDICINE
- The network of Shanghai Stroke Service System (4S): A public health-care web-based database using automatic extraction of electronic medical records
- (2018) Yi Dong et al. International Journal of Stroke
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
- (2018) Raul G. Nogueira et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes
- (2018) Taku Inohara et al. JAMA Cardiology
- Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial
- (2017) Lily Song et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Finding the Right t-PA Dose for Asians with Acute Ischemic Stroke
- (2016) Cathy Sila NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
- (2016) Craig S. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Versus Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations
- (2015) Meng-Dong Liu et al. MEDICINE
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
- (2015) Bruce C.V. Campbell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses
- (2014) Xiaoling Liao et al. STROKE
- Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome
- (2014) William N. Whiteley et al. STROKE
- Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
- (2013) Rachael L DiSantostefano et al. BMJ Open
- Symptomatic intracranial hemorrhage after stroke thrombolysis: The SEDAN Score
- (2012) Daniel Strbian et al. ANNALS OF NEUROLOGY
- Optimal dose for stroke thrombolysis in Asians: low dose may have similar safety and efficacy as standard dose
- (2012) C.-H. CHEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase
- (2012) Michael Mazya et al. STROKE
- Feasibility and Safety of Intravenous Thrombolysis in Multiethnic Asian Stroke Patients in Singapore
- (2010) Vijay K. Sharma et al. Journal of Stroke & Cerebrovascular Diseases
- Outcomes of Thrombolytic Therapy for Acute Ischemic Stroke in Chinese Patients
- (2010) A-Ching Chao et al. STROKE
- A Risk Score to Predict Intracranial Hemorrhage After Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
- (2008) Brett Cucchiara et al. Journal of Stroke & Cerebrovascular Diseases
- The HAT Score: A simple grading scale for predicting hemorrhage after thrombolysis
- (2008) M. Lou et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started